CAMBRIDGE, Mass., June 16 /PRNewswire/ -- Sirtris Pharmaceuticals, the leading sirtuin therapeutics company, today announced that its Chief Executive Officer, Christoph Westphal, M.D., Ph.D., has been awarded the Ernst & Young New England Entrepreneur of the Year in the category Biopharmaceutical. The Ernst & Young award celebrates the role of the entrepreneurial spirit in the development of new technologies, the improvement of quality of life, and the creation of strong and vibrant corporations. Dr. Westphal was among several regional entrepreneurs who were honored last night at an event hosted by Ernst & Young in Boston, Massachusetts.
